EUCTR2007-006151-40-IT进行中（未招募）不适用
FT/LEUCOVORIN AND MITOMYCIN C IN THE TREATMENT OF METASTATIC COLORECTAL CANCER OXALIPLATIN AND IRINOTECAN RESISTANT - MITOUFT
AZIENDA OSPEDALIERA S. LUIGI GONZAGA0 个研究点开始时间: 2007年11月28日最近更新:
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •PATIENTS WITH DIAGNOSIS OF METASTATIC COLORECTAL CANCER OXALIPLATIN AND IRINOTECAN RESISTANT
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •PREVIOUS CHEMOTHERAPY WITH MITHOMYCIN C AND/OR UFT/LEUCOVORIN
研究者
相似试验
进行中（未招募）
1 期
Continuous fluorouracil plus mitomycin C versus mitomycin C plus Cisplatin as chemotherapy combination in combined radiochemotherapy for locally advanced anal cancer. A phase II-III studyocally Advanced Anal CancerMedDRA version: 9.1Level: LLTClassification code 10061629Term: Anal neoplasmEUCTR2004-000329-31-ITE.O.R.T.C. - EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER678
进行中（未招募）
不适用
CETUXIMAB AND FOLFIRI AS FIRST-LINE TREATMENT OF LOCALLY ADVANCED AND METASTATIC GASTRIC CANCEREUCTR2004-004072-37-ITAZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI25
已完成
2 期
Topical Mitomycin C application in management of localized caustic esophageal stricture in children: A double-blinded randomized placebo-controlled trialcaustic esophageal strictureOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colonACTRN12612000683831Ain Shams University40
已完成
不适用
Mitomycin, ifosfamide and cisplatin in non-small cell lung cancer (NSCLC): A randomised trial of chemotherapy plus radiotherapy versus radiotherapy aloneung (non-small cell) cancerLung (non-small cell)CancerISRCTN56319613Cancer Research UK (CRUK) (UK)
已完成
2 期
Study PDX-LVRelapsed/Refractory peripheral T-cell lymphoma(r/r PTCL)JPRN-jRCT2080224048MUNDIPHARMA K.K.13